Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Pierre Chamouni"'
Autor:
Ngoc Anh Thu Nguyen, Pascal Auquier, Any Beltran Anzola, Roseline D’oiron, Thierry Lambert, Céline Falaise, Christine Biron, Anne Lienhart, Jenny Goudemand, Antoine Rauch, Bénédicte Wibaut, Sabine Marie Castet, Dominique Desprez, Annie Harroche, Natalie Stieltjes, Annie Borel-Derlon, Marc Trossaërt, Amandine Celli, Benoît Guillet, Sophie Bayart, Marie-Anne Bertrand, Alexandra Fournel, Guillaume Mourey, Valérie Gay, Pierre Chamouni, Emmanuelle DE Raucourt, Birgit Frotscher, Michèle Martin, Mathieu Puyade, Brigitte Tardy, Stéphane Vanderbecken, Fabienne Genre-Volot, Philippe Nguyen, Benoît Polack, Caroline Oudot-Challard, Stéphane Girault, Annelise Voyer, Aurélien Lebreton, Abel Hassoun, Philippe Moreau, Pierre-Simon Rohrlich, Karine Baumstarck, Mohamed Boucekine, Vanessa Milien, Natacha Rosso, Clemence Tabele, Marie Viprey, Nicolas Giraud, Thomas Sannie, Hervé Chambost, Noémie Resseguier
Publikováno v:
HemaSphere, Vol 7, p e623777c (2023)
Externí odkaz:
https://doaj.org/article/35f0ccb00974432f92e9847dd92e5503
Autor:
Quentin Allard, Zoubir Djerada, Claire Pouplard, Yohann Repessé, Dominique Desprez, Hubert Galinat, Birgit Frotscher, Claire Berger, Annie Harroche, Anne Ryman, Claire Flaujac, Pierre Chamouni, Benoît Guillet, Fabienne Volot, Jean Szymezak, Philippe Nguyen, Yoann Cazaubon
Publikováno v:
Pharmaceutics, Vol 12, Iss 4, p 380 (2020)
We retrospectively analysed the data files of 171 adults and 87 children/adolescents with severe haemophilia, except for 14 patients (moderate; minor) (1), to develop a global population pharmacokinetic (PK) model for eight factors VIII (FVIII) that
Externí odkaz:
https://doaj.org/article/489d0d90c7db48c09669f63385bc360c
Autor:
Benoit Guillet, Abel Hassoun, Bénédicte Wibaut, Annie Harroche, Christine Biron-Andréani, Yohan Repesse, Roseline d'Oiron, Brigitte Tardy, Brigitte Pan Petesch, Pierre Chamouni, Valérie Gay, Marc Fouassier, Claire Pouplard, Cédric Martin, Hasan Catovic, Xavier Delavenne
Publikováno v:
Thrombosis and Haemostasis. 123:490-500
Background rVIII-SingleChain is a recombinant factor VIII (FVIII) with increased binding affinity to von Willebrand factor compared with other FVIII products. rVIII-SingleChain is indicated for the treatment and prevention of bleeding episodes in pat
Publikováno v:
Journal of Stomatology, Oral and Maxillofacial Surgery. 123:e405-e410
The management of patients with inherited bleeding disorders in oral surgery requires the systematic evaluation of bleeding risk and the setting up of an adequate treatment protocol by the referring haematologist, defining a replacement therapy and a
Autor:
Brigitte Tardy, Thierry Lambert, Pierre Chamouni, Aurélie Montmartin, Marc Trossaert, Ségolène Claeyssens, Claire Berger, Laurent Ardillon, Valérie Gay, Xavier Delavenne, Annie Harroche, Pierre Chelle
Publikováno v:
Haemophilia. 28:542-547
Nonacog alfa, a standard half-life recombinant factor IX (FIX), is used as a prophylactic treatment in severe haemophilia B (SHB) patients. Its half-life determined in clinical studies involving a limited sampling (72 h) was shown to be rather short.
Autor:
Philippe Gautier, Benoit Guillet, Marianne Sigaud, Ségolène Claeyssens, Fabienne Genre Volot, Pierre Chamouni, Anne Lienahrt, Birgit Frotscher, Alexandra Fournel, Sabine Castet, Catherine Poumayou, Valérie Gay, Rodolphe Thuret, Bénédicte Wibaut, Christine Biron‐Andreani
Publikováno v:
Haemophilia. 28:437-444
Data are limited on prostate cancer (PC) management in patients with haemophilia (PWH).To describe PC screening and diagnosis, treatment modalities and bleeding complications in a group of unselected PWH followed at French Haemophilia Treatment Centr
Autor:
Justine Hugon-Rodin, Camille Carrière, Ségolène Claeyssens, Nathalie Trillot, Nicolas Drillaud, Christine Biron-Andreani, Cécile Lavenu-Bombled, Anna Wieland, Claire Flaujac, Natalie Stieltjes, Aurélien Lebreton, Thomas Brungs, Andrea Hegglin, Mathieu Fiore, Céline Desconclois, Valérie Gay, Brigitte Tardy-Poncet, Philippe Beurrier, Virginie Barbay, Pierre Chamouni, Emmanuel De Maistre, Tomas Simurda, Alessandro Casini
BACKGROUND Women with hereditary fibrinogen disorders (HFDs) seem to be at increased risk of adverse obstetrical outcomes, but epidemiologic data are limited Patients/methods: We conducted a retrospective and prospective international study to determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e0f4e913709c7a5ad5af681f0553bf4
Autor:
Sabine Brunel, Guillaume Feugray, Marielle Fresel, Virginie Barbay, Véronique Le Cam Duchez, Pierre Chamouni, Paul Billoir, Marie Hélène Chrétien, Fiston Kasonga
Publikováno v:
Clinica Chimica Acta. 523:348-354
Factor XI (FXI) deficiency is characterized by a lack of correlation between FXI plasma levels and the occurrence of hemorrhagic events. The main objective of our study was to determine whether thrombin generation assay (TGA) could be used to assess
Autor:
Nathalie Grinda, Francoise Truong-Berthoz, Edita Dolimier, Emmanuelle Ferré, Birgit Frotscher, Emmanuelle de Raucourt, Valerie Roussel-Robert, Sophie Bayart, Sandrine Meunier, Sophie le Doré, Pierre Chamouni
Publikováno v:
Journal of Blood Medicine
Sophie le Doré,1 Nathalie Grinda,2 Emmanuelle Ferré,1 Valerie Roussel-Robert,3 Birgit Frotscher,4 Pierre Chamouni,5 Sandrine Meunier,6 Sophie Bayart,7 Edita Dolimier,8 Francoise Truong-Berthoz,9 Emmanuelle de Raucourt1 1Haemophilia Treatment Centre
Autor:
Lucia Rugeri, Annie Harroche, Yohan Repessé, Dominique Desprez, Brigitte Pan Petesch, Pierre Chamouni, Christine Biron, Birgit Frotscher, Hasan Catovic, Diane Bracquart, Cédric Martin, Marc Trossaërt, Sandrine Meunier, Roseline d'Oiron
Publikováno v:
European journal of haematology. 109(1)
Patients with symptomatic von Willebrand disease (VWD) should be offered long-term prophylaxis (LTP) to prevent recurrent bleedings. Our objective was to evaluate the effectiveness and safety of Voncento®, a plasma-derived FVIII/VWF concentrate (rat